We attended the 2023 World Drug Safety Congress Europe in Amsterdam, an esteemed event that brought together professionals and experts from around the globe to discuss and collaborate on advancements in drug safety.
We welcomed attendees to visit us at Booth 91, where we showcased our groundbreaking technology PROHALO that is revolutionizing drug safety. Our team was available to provide in-depth insights into how our technology is transforming the landscape of the pharmacovigilance industry. If you wanted to learn more about our collaboration with the Medicines and Healthcare Products Regulatory Agency (MHRA), you could have listened to Sarah Vaughn's presentation titled 'MHRA Digital Transformation Journey.'
Jen Markey, our Chief Sales & Marketing Officer, presented on the 'Evolution of Safety Systems.' Her presentation offered valuable perspectives on the evolving nature of safety systems in pharmacovigilance.
We eagerly anticipated the visits of our guests at Booth 91 and looked forward to engaging in stimulating discussions with them about the future of drug safety. Together, we worked toward a safer and healthier world. It was a pleasure to have seen you at the 2023 World Drug Safety Congress Europe!